Table 5 Comparison of age between different groups of COVID-19 patients with and without heart disease and healthy participants (control).

From: Association of DHEAS levels with COVID19 severity, gender, age, comorbidities, and management strategies

 

Age (years)

N

Mean ± SD

Median

Q1

Q3

p.value1

p.value2

p.value3

p.value4

1

HD Positive/ Patient

84

64 ± 13

65

55

75

    

2

HD Negative / Patient

514

48 ± 16

46

35

58

< 0.001

   

3

HD Negative / Control

70

47 ± 14

50

35

57

< 0.001

0.544

  

1

HD Positive / Inpatient

71

65 ± 14

67

55

78

    

2

HD Positive / Outpatient

13

62 ± 11

59

52

70

0.408

   

3

HD Negative / Inpatient

275

53 ± 16

51

40

65

< 0.001

0.054

  

4

HD Negative / Outpatient

239

42 ± 13

40

32

52

< 0.001

< 0.001

< 0.001

 

5

HD Negative / Control

70

47 ± 14

50

35

57

< 0.001

< 0.001

0.003

0.011

1

HD Positive / patient

Female

37

64 ± 14

66

53

75

    

Male

47

65 ± 13

64

55

78

0.651

   

2

HD Negative / patient

Female

218

48 ± 16

46

35

60

    

Male

296

48 ± 16

46

36

58

0.747

   

3

HD Negative / control

Female

28

48 ± 13

53

38

58

    

Male

42

45 ± 14

47

35

55

0.373

   
  1. P-value 1 compares group1 with other groups and p-value 2 compares group 2 with other groups. P-value 3 compares group 3 with other groups. P-value 4 compares group 4 with group 5. P-value < = 0.05 is significant.
Back to article page